DR. DON W. SHAFFER, MD

MARIETTA, GA

Research Active
Internal Medicine - Hematology & Oncology NPI registered 21+ years 50 publications 2016 – 2026 NPI: 1124023452
Tissue DonorsGraft SurvivalPrognosisPostoperative ComplicationsKidney TransplantationKidneyTransplant RecipientsAntineoplastic Combined Chemotherapy ProtocolsWaiting ListsHepacivirusKidney Failure, ChronicHIV InfectionsHepatitis CHepatitis C, ChronicBlood Group Incompatibility

Practice Location

340 KENNESTONE HOSPITAL BLVD STE 100
MARIETTA, GA 30060-1158

Phone: (770) 281-5100

What does DON SHAFFER research?

Dr. Shaffer conducts research in both medical and environmental fields. In surgery and transplantation, he investigates how different factors like donor health and surgical experience affect patient outcomes, particularly in kidney and heart-kidney transplants. He also looks into conditions that emerge post-transplant, such as Passenger Lymphocyte Syndrome, which can lead to complications for patients. On the environmental side, his studies explore how wildlife, including birds and other animals, respond and adapt to severe weather events like tropical cyclones, which is vital for conservation efforts and understanding ecosystem resilience.

Key findings

  • Found that 40% of severely obese patients who underwent bariatric surgery were listed for kidney transplants within 18 months, compared to 25% of those using medical weight loss strategies.
  • Identified that HCV-positive kidneys from deceased donors had minimal glomerulosclerosis in 61.2% of cases, similar to 49% in uninfected kidneys, showing both groups had good transplant performance after a year.
  • Discovered that only 15% of kidney transplant recipients from HCV-positive donors developed cytomegalovirus infections, compared to 11% from HCV-negative donors, with no significant risk increase.

Frequently asked questions

Does Dr. Shaffer study organ transplantation?
Yes, Dr. Shaffer investigates various aspects of organ transplantation, including complications post-transplant and factors affecting kidney transplant success.
What treatments has Dr. Shaffer researched?
He has looked into treatments for patients receiving organs from hepatitis C-positive donors and the effectiveness of weight loss strategies for those undergoing kidney transplants.
Is Dr. Shaffer's work relevant to patients needing kidney transplants?
Certainly! His research provides insights into donor health and complications, helping healthcare providers make better decisions for transplant patients.
Does Dr. Shaffer study wildlife and environmental changes?
Yes, he researches how wildlife, like certain bird species, adapt to extreme weather events, which is crucial for conservation efforts.
What are Dr. Shaffer's findings related to vaccines in Africa?
He highlighted that Africa gets less than 2% of global vaccine research funding, emphasizing the need for local vaccine development to address health crises effectively.

Publications in plain English

How wildlife respond to tropical cyclones: short-term tactics and long-term impacts.

2026

Biological reviews of the Cambridge Philosophical Society

Koen EL, Meliane MK, Holmes ZB, Miller KE, Barichivich WJ +11 more

Plain English
This research paper studied how different types of wildlife respond to tropical cyclones, like hurricanes, and the effects these storms have on their populations. It found that animals like butterflies, lizards, sharks, and seabirds use various strategies to survive the storms; some move to safer areas while others stay put. The study also noted that while storms can harm wildlife directly, they can create long-term changes in habitats and resources that affect animal populations, sometimes even helping certain species thrive. Who this helps: This research helps conservationists and wildlife managers in protecting animal populations during and after extreme weather events.

PubMed

Medical and Surgical Weight Loss as a Pathway to Renal Transplant Listing.

2025

The American surgeon

Samuels JM, English W, Birdwell KA, Feurer ID, Shaffer D +2 more

Plain English
This study looked at two ways to help severely obese patients on dialysis lose weight so they can be listed for a kidney transplant: bariatric surgery (MBS) and medical weight loss (MM). Out of the patients who received treatment, 40% of those who had bariatric surgery were listed for a transplant within 18 months compared to 25% of those who used medical weight loss. In the long run, all of the bariatric surgery patients were listed for a transplant, while only 25% of the medical weight loss group achieved that, showing that bariatric surgery is more effective for weight loss and getting listed for transplants. Who this helps: This helps patients who are obese and on dialysis seeking kidney transplants.

PubMed

Factors Impacting Early Adverse Outcomes in Simultaneous Heart-Kidney Transplantation.

2025

Transplantation proceedings

DuBray BJ, Shawar S, Zalawadiya S, Schlendorf K, Sarrell BA +5 more

Plain English
This study looked at the challenges faced by patients receiving heart-kidney transplants, specifically focusing on early complications that can occur like delayed kidney function and transplant failure. Out of 68 patients, 35% had delayed kidney function, 6% experienced kidney failure right away, and 18% faced overall transplant failure. The researchers found that certain factors, like needing dialysis before the transplant and how long the kidneys were without blood, increased the chances of these complications, which is important because it highlights the need for better strategies to improve outcomes for these patients. Who this helps: Patients undergoing heart-kidney transplants and their healthcare providers.

PubMed

Risk of Cytomegalovirus Viremia Following Transplantation of Hepatitis C-Viremic Donor Kidneys Into Uninfected Recipients: A Multi-Center Retrospective Cohort Study.

2025

Transplant infectious disease : an official journal of the Transplantation Society

Potluri VS, Goldberg D, Zhang S, Schaubel DE, Molnar MZ +17 more

Plain English
This research looked at kidney transplant recipients who received organs from donors infected with Hepatitis C (HCV) to see if they faced a higher risk of developing cytomegalovirus (CMV) infections. The study involved 275 recipients and found that 15% of those who received HCV-positive kidneys experienced CMV viremia, compared to 11% of those who received HCV-negative kidneys. Importantly, there was no significant difference in risk, meaning HCV-positive donor kidneys do not increase the likelihood of CMV infections for uninfected recipients. Who this helps: This information benefits kidney transplant patients and their doctors by helping them make informed decisions regarding donor organ selection.

PubMed

Passenger Lymphocyte Syndrome Presenting With Severe Refractory Thrombocytopenia After Transplantation: A Multi-Recipient Case Series.

2025

Clinical transplantation

Larson EE, Aravena C, Kulkarni DP, Mouch CA, Forbes RC +4 more

Plain English
This study looked at a condition called Passenger Lymphocyte Syndrome (PLS) that can happen after organ transplants. It found that several patients who received organs from the same donor developed a serious drop in blood platelets, making it difficult to stop bleeding. In these cases, the immune response from the donor's cells was attacking the patients' own blood cells. Who this helps: This research benefits doctors and patients who are considering or have undergone organ transplantation.

PubMed

A landscape analysis of the vaccine ecosystem in Africa: research and development funding, clinical trials, regulation, and manufacturing readiness.

2025

The Lancet. Global health

Fleck-Vidal C, Le Moal A, Mogeni OD, Shaffer D, Canouet V +4 more

Plain English
This study looked at how Africa handles vaccine research, funding, clinical trials, and production. It found that Africa receives less than 2% of global funding for vaccine research, with most of it coming from wealthy countries, and only 8% of vaccine clinical trials happen there. This matters because Africa, despite facing many infectious diseases, relies heavily on vaccines from outside, which limits its ability to respond to health crises. Who this helps: This helps African countries and their health systems by highlighting the need for local vaccine development and production.

PubMed

Low prevalence of glomerulonephritis in transplanted kidneys from deceased donors with active hepatitis C virus infection.

2025

Kidney international

Reese PP, Mohan S, Schaubel DE, Forbes R, Mehta S +20 more

Plain English
This study looked at the health of kidneys transplanted from deceased donors with an active hepatitis C virus (HCV) infection compared to those from donors without the virus. Researchers found that diseases affecting the kidney's filtering units, known as glomerulonephritis, were rare in both groups, with 61.2% of kidneys from HCV donors showing little to no glomerulosclerosis compared to 49% from non-HCV donors. This information is important because it suggests that kidneys from HCV-infected donors are often just as healthy as those from uninfected donors, which could lead to more transplant options for patients in need. Who this helps: This helps patients waiting for kidney transplants.

PubMed

A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma.

2024

European urology oncology

Msaouel P, Sweis RF, Bupathi M, Heath E, Goodman OB +19 more

Plain English
This study investigated the combination of two cancer treatments, sitravatinib and nivolumab, in patients with advanced bladder cancer that is hard to treat. Out of 244 patients, the response to treatment was quite low, with only 32% of those who hadn’t received prior treatment seeing any improvement, and much lower rates of about 5% among those whose cancer had already resisted other therapies. Although the treatment had manageable side effects, it did not significantly help most patients, highlighting a need for more effective options. Who this helps: This helps doctors and researchers understand the challenges in treating advanced bladder cancer and identify areas for further research.

PubMed

Twelve-month kidney and liver outcomes of kidney transplantation from Hepatitis C Viremic deceased donors to aviremic recipients.

2024

Transplant infectious disease : an official journal of the Transplantation Society

Binari LA, Thorne P, Rega SA, Feurer ID, Shawar S +12 more

Plain English
This study examined the long-term health of patients who received kidney transplants from donors with Hepatitis C compared to those who received kidneys from donors without the virus. Over the first year, both groups showed similar kidney function, with no significant differences in kidney health measures. Although a higher percentage of the Hepatitis C donor group had elevated liver enzymes early on (23% compared to 6%), these levels normalized over time, and no liver complications were found related to the Hepatitis C virus. Who this helps: This research benefits kidney transplant recipients, particularly those receiving organs from Hepatitis C-infected donors.

PubMed

Kidney Transplantation Anastomotic Time Is Jointly Associated With Resident and Attending Experience.

2024

The Journal of surgical research

Godfrey CM, Rausch LA, Feurer ID, Rega SA, Shaffer D +4 more

Plain English
This study looked at how the experience level of both attending surgeons and resident doctors affects the time it takes to connect blood vessels during kidney transplants. Researchers analyzed 1,306 kidney transplants and found that certain pairings of the less experienced attendings and residents resulted in longer connection times, particularly when early practice attendings were teamed up with PGY-2 or PGY-3 residents. Improving surgical training by matching residents and attendings based on their experience could lead to better transplant outcomes and faster procedures. Who this helps: This helps patients undergoing kidney transplants.

PubMed

A2/A2B to B kidney transplantation outcomes: A single center 7-year experience.

2024

Clinical transplantation

El Chediak A, Shawar S, Fallahzadeh MK, Forbes R, Schaefer HM +4 more

Plain English
This study looked at the outcomes of kidney transplants from A2/A2B donors to B recipients over a seven-year period. Researchers found that the survival rates, kidney function, and rejection rates for these transplants were similar to those from B to B donor transplants, with no significant differences in their success. This is important because it shows that A2/A2B kidneys can be a viable option for B recipients, potentially increasing the number of available transplants. Who this helps: This helps kidney transplant patients and healthcare providers by providing more options for organ donation.

PubMed

Inaccuracy of Initial Clinical Mobility Assessment in Venous Thromboembolism Risk Stratification.

2024

The American journal of medicine

Hoyer EH, Bhave A, Xue W, Haut ER, Lau BD +7 more

Plain English
Researchers looked at how accurate initial assessments of patient mobility in hospitals were when determining the risk of blood clots in patients. They found that using an objective scoring system (called JH-HLM) identified a much higher percentage of patients with reduced mobility—19.1% compared to only 6.5% identified by health care professionals—leading to possible misclassification of risk. Correctly assessing mobility is important because 33 patients out of 1,715 developed blood clots, and many high-risk patients might not receive the preventive measures they need. Who this helps: This helps patients at risk of blood clots, as well as doctors who can make better-informed treatment decisions.

PubMed

Food availability aligns with contrasting demographics in populations of an at-risk songbird.

2024

Ecology and evolution

Keele EC, Fiss CJ, McNeil DJ, Anderson M, Thomas N +2 more

Plain English
This study looked at two groups of Golden-winged Warblers in Pennsylvania to understand why one group is thriving while the other is struggling. Researchers found that the central population had 45 times fewer caterpillars, which are the main food for these birds, compared to the eastern population. The eastern warblers also had better body weight and fledgling growth, indicating they have more energy and resources for survival. Who this helps: This research benefits conservationists and wildlife managers working to protect at-risk bird populations.

PubMed

Enhanced triplet superconductivity in next-generation ultraclean UTe.

2024

Proceedings of the National Academy of Sciences of the United States of America

Wu Z, Weinberger TI, Chen J, Cabala A, Chichinadze DV +15 more

Plain English
This study focused on a unique material called UTe, which can conduct electricity without resistance under certain conditions, a property important for advanced technologies like quantum computers. The researchers discovered that the quality of the UTe crystals significantly affects how they behave under strong magnetic fields, leading to new insights on their superconducting properties. They found that when the crystals are more pristine, the superconductivity becomes more sensitive to changes in magnetic fields, which could help refine our understanding of these materials. Who this helps: This benefits physicists and engineers working on quantum computing technologies.

PubMed

High Rates of Anxiety Among Adolescents in a Partial Hospitalization Program.

2023

Child & youth care forum

Pelcovitz M, Bennett S, Desai P, Schild J, Beaumont R +3 more

Plain English
This study looked at how common anxiety disorders are among teenagers in a partial hospitalization program for mental health treatment. They found that 75% of the 158 teens studied were diagnosed with an anxiety disorder, and those with anxiety scored high on measures of anxiety severity. This is important because it shows that anxiety is a major issue for these kids, highlighting the need for better assessment and treatment options in these settings. Who this helps: This helps adolescents struggling with anxiety, their families, and mental health professionals.

PubMed

Incisional Hernia Development after Live Donor Nephrectomy: Impact of Surgical Technique.

2023

Kidney360

DuBray BJ, Tompson JJ, Shaffer D, Hale DA, Rega SA +2 more

Plain English
This study looked at how often incisional hernias occur after kidney donation surgery and found that 9.3% of patients developed a hernia within three years, typically around 7 months after their surgery. Researchers discovered that being obese and the type of incision made during the surgery increased the chances of developing a hernia. This is important because finding ways to reduce hernia development can improve recovery and quality of life for kidney donors. Who this helps: Kidney donors and their surgeons.

PubMed

Emergence of the Chern Supermetal and Pair-Density Wave through Higher-Order Van Hove Singularities in the Haldane-Hubbard Model.

2023

Physical review letters

Castro P, Shaffer D, Wu YM, Santos LH

Plain English
This study explores how certain electronic arrangements behave in materials where the shape of their electronic energy bands is altered. Researchers found that when they changed certain conditions, new electronic states emerged, including a unique form of superconductivity and magnetic order. This is important because it could lead to breakthroughs in developing advanced materials for electronics and quantum computing. Who this helps: This helps researchers and engineers working on new materials for technology.

PubMed

Unleashing the Power of NR4A1 Degradation as a Novel Strategy for Cancer Immunotherapy.

2023

bioRxiv : the preprint server for biology

Wang L, Xiao Y, Luo Y, Master RP, Mo J +11 more

Plain English
Researchers studied a molecule called NR4A1, which helps cancer cells grow and keeps the protective immune cells in tumors from working properly. They created a new drug, NR-V04, that targets and breaks down NR4A1, effectively stopping tumor growth and sometimes completely eliminating melanoma tumors. This method not only reduces NR4A1 levels quickly and safely but also improves the body's immune response against cancer. Who this helps: This benefits cancer patients, especially those with melanoma.

PubMed

The Kidney Transplant: Maintaining Excellent Outcomes While Increasing Skills Acquisition.

2023

Journal of surgical education

Rausch LA, McKay KG, Liu Y, Walker JC, LeCompte MT +6 more

Plain English
This study looked at how surgical residents improve their skills while performing kidney transplants and whether their involvement affects patient outcomes. It found that as residents did more kidney transplants, the time it took them to complete a critical part of the operation decreased significantly, while there were no negative effects on patient outcomes, such as complications after surgery. This is important because it means that training residents can help them become more efficient without putting patients at risk. Who this helps: This helps surgical residents and their patients by ensuring effective training while maintaining safety in surgeries.

PubMed

Association of donor hepatitis C virus infection status and risk of BK polyomavirus viremia after kidney transplantation.

2022

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Molnar MZ, Potluri VS, Schaubel DE, Sise ME, Concepcion BP +19 more

Plain English
This study looked at kidney transplants from donors infected with hepatitis C virus (HCV) and their impact on a potential complication called BK polyomavirus (BKPyV) in patients who did not have HCV. Researchers found that while HCV-infected kidneys did not significantly increase the chance of lower levels of BKPyV (1,000 copies/ml or higher), there was a higher risk of more severe BKPyV levels (10,000 copies/ml or higher), with a risk increase of 69%. However, kidney function for patients who received HCV-positive kidneys was still good at one year post-transplant. Who this helps: This information benefits kidney transplant patients and their doctors by providing insights into the risks associated with HCV-infected donors.

PubMed

Development and validation of technologies suitable for the decontamination and re-use of contaminated N95 filtering facepiece respirators in response to the COVID-19 pandemic.

2022

The Journal of hospital infection

Alt J, Eveland R, Fiorello A, Haas B, Meszaros J +5 more

Plain English
This study looked at ways to safely clean and reuse N95 face masks, which are essential for healthcare workers during the COVID-19 pandemic. Researchers found that using steam and vaporized hydrogen peroxide effectively inactivated harmful bacteria and viruses without damaging the masks; they achieved a reduction of over 99.9% for bacteria and 99.9% for viruses. These findings are important because they show that it's possible to extend the life of masks, ensuring healthcare workers have the protective gear they need in crisis situations. Who this helps: This helps healthcare workers who need effective personal protective equipment.

PubMed

Brief Report: No Differences Between Lopinavir/Ritonavir and Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy on Clearance of Plasmodium falciparum Subclinical Parasitemia in Adults Living With HIV Starting Treatment (A5297).

2022

Journal of acquired immune deficiency syndromes (1999)

Shaffer D, Kumwenda J, Chen H, Akelo V, Angira F +10 more

Plain English
This study looked at whether two different types of HIV treatments—one that includes the drug lopinavir/ritonavir and another based on nonnucleoside reverse transcriptase inhibitors—work differently in clearing a malaria infection called subclinical parasitemia from the blood. They found no significant difference after 15 days: 23% of those on the lopinavir/ritonavir-based treatment and 27% of those on the other treatment cleared the malaria infection, which means both treatments were similarly effective. This matters because it shows that patients can use either treatment without worrying about their malaria clearance rate being affected. Who this helps: This helps adults living with HIV who might also have malaria.

PubMed

Nivolumab plus docetaxel in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: results from the phase II CheckMate 9KD trial.

2022

European journal of cancer (Oxford, England : 1990)

Fizazi K, González Mella P, Castellano D, Minatta JN, Rezazadeh Kalebasty A +13 more

Plain English
This study looked at the combination of two drugs, nivolumab and docetaxel, in treating patients with advanced prostate cancer who had not yet received chemotherapy. Out of 84 patients treated, 40% showed a positive response to the therapy, and 47% had a significant decrease in prostate-specific antigen (PSA) levels. The average time until the disease progressed was about 9 months, while overall survival was about 18 months, indicating that this combined treatment approach could be effective for this patient group. Who this helps: This benefits patients with advanced, treatment-resistant prostate cancer.

PubMed

Association between severe anaemia and inflammation, risk of IRIS and death in persons with HIV: A multinational cohort study.

2022

EBioMedicine

Ara Jo-Pereira M, Sheikh V, Sereti I, Barreto-Duarte B, Arriaga MÍB +11 more

Plain English
This study looked at how severe anaemia impacts people with HIV who are starting treatment. Researchers found that among HIV patients with severe anaemia, 25% experienced a condition called Immune Reconstitution Inflammatory Syndrome (IRIS), which can lead to serious complications and even deaths, with those affected at a higher risk for early IRIS and mycobacterial infections. The findings highlight the importance of monitoring and treating severe anaemia in HIV patients to improve their health outcomes. Who this helps: This helps patients with HIV, especially those experiencing anaemia.

PubMed

Cocaine sensitizes the CD4T cells for HIV infection by co-stimulating NFAT and AP-1.

2022

iScience

Sharma AL, Shaffer D, Netting D, Tyagi M

Plain English
This study looked at how cocaine affects a type of immune cell (CD4T cells) and their ability to get infected by HIV. Researchers found that cocaine makes these cells more likely to support HIV infection by activating certain factors that help the virus reproduce. Specifically, they observed that cocaine increases the activity of two important proteins (NFAT and AP-1) in these cells, leading to higher levels of HIV production. Who this helps: This research benefits patients who use cocaine and are at risk for HIV infection.

PubMed

Unconventional self-similar Hofstadter superconductivity from repulsive interactions.

2022

Nature communications

Shaffer D, Wang J, Santos LH

Plain English
This research studied a type of superconductivity in special materials known as Hofstadter bands, which can be created using layered structures called moiré superlattices. The researchers found that by adjusting certain conditions, they could create new and unusual superconducting behaviors, specifically noting the presence of Van Hove singularities, which lead to specific superconducting qualities. This is important because it shows that these advanced materials could be used to develop innovative superconducting technologies that may improve electrical energy efficiency. Who this helps: This benefits researchers and engineers working on advanced materials and energy-related technologies.

PubMed

An Inflammatory Composite Score Predicts Mycobacterial Immune Reconstitution Inflammatory Syndrome in People with Advanced HIV: A Prospective International Cohort Study.

2021

The Journal of infectious diseases

Vinhaes CL, Sheikh V, Oliveira-de-Souza D, Wang J, Rupert A +9 more

Plain English
This study investigated a condition called immune reconstitution inflammatory syndrome (IRIS) in people with advanced HIV who start treatment. Researchers measured certain blood markers in patients with severely weakened immune systems and found a combination of these markers that could predict who would develop mycobacterial IRIS or die after starting treatment. Specifically, they created a score based on markers like interleukin-6 and others that accurately indicated the risk of complications, helping doctors better manage these patients. Who this helps: This benefits patients with advanced HIV and their healthcare providers.

PubMed

Attaining 95-95-95 through Implementation Science: 15 Years of Insights and Best Practices from the Walter Reed Army Institute of Research's Implementation of the U.S. President's Emergency Plan for AIDS Relief.

2021

The American journal of tropical medicine and hygiene

Lee EH, Ganesan K, Khamadi SA, Meribe SC, Njeru D +13 more

Plain English
The study examines how the Walter Reed Army Institute of Research has improved HIV treatment for over 350,000 people in Kenya, Nigeria, Tanzania, and Uganda through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) over the last 15 years. They found that their efforts enhanced health services, which helped reach the 95-95-95 goals—aiming for 95% of people with HIV to know their status, 95% of those diagnosed to receive treatment, and 95% of those treated to achieve viral suppression. This is important because it shows how targeted investments in health strategies can lead to better outcomes and combat the HIV epidemic effectively. Who this helps: This benefits patients living with HIV, especially in African countries.

PubMed

Kidney Transplantation From Hepatitis C Viremic Deceased Donors to Aviremic Recipients in a Real-world Setting.

2021

Transplantation direct

Concepcion BP, Binari LA, Schaefer H, Rega S, Feurer I +18 more

Plain English
This study looked at kidney transplants from donors who had hepatitis C (HCV+) to recipients who did not have the virus (HCV-). Researchers found that the health outcomes for these recipients were similar to those who received kidneys from donors without the virus, with both groups showing no significant differences in kidney function or rates of complications within the first six months. Almost all of the recipients from HCV+ donors were successfully treated for the virus after their transplant, demonstrating that this approach can expand the availability of kidneys for transplant without compromising patient health. Who this helps: This benefits patients in need of kidney transplants, particularly those who might have limited options due to a shortage of organs.

PubMed

Association between ezetimibe usage and hepatitis C RNA levels in uninfected kidney transplant recipients who received hepatitis C infected kidneys.

2021

Clinical transplantation

Azhar A, Binari LA, Joglekar K, Tsujita M, Talwar M +9 more

Plain English
This study looked at kidney transplant recipients who received organs from hepatitis C-infected donors but were uninfected themselves. It found that patients taking the drug ezetimibe had significantly lower levels of hepatitis C virus in their blood—about one log lower—compared to those who didn't take the drug, which could help manage the virus before starting more direct treatments. This is important because it suggests that ezetimibe might help lower viral loads in these patients while they wait for more effective antiviral therapies. Who this helps: This benefits kidney transplant patients receiving organs from hepatitis C-positive donors.

PubMed

COVID-19 Risk Factors and Mortality Outcomes Among Medicare Patients Receiving Long-term Dialysis.

2021

JAMA network open

Salerno S, Messana JM, Gremel GW, Dahlerus C, Hirth RA +19 more

Plain English
This study looked at the impact of COVID-19 on Medicare patients who are on long-term dialysis. Out of nearly half a million patients, about 12.1% contracted COVID-19, and among those, 26% died. The study found that Black and Hispanic patients had higher rates of COVID-19, and those who stayed in nursing homes were at greater risk for both infection and death. Who this helps: This information benefits patients and healthcare providers by identifying high-risk groups and guiding better care.

PubMed

Prospective International Study of Incidence and Predictors of Immune Reconstitution Inflammatory Syndrome and Death in People Living With Human Immunodeficiency Virus and Severe Lymphopenia.

2020

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Sereti I, Sheikh V, Shaffer D, Phanuphak N, Gabriel E +18 more

Plain English
This study looked at people living with HIV who had very low immune cell counts (under 100 cells/μL) and started treatment to see how many developed a condition called immune reconstitution inflammatory syndrome (IRIS) or died within six months. Out of 506 participants, 19.2% experienced IRIS and 6.5% died. The researchers found that those with lower hemoglobin levels had a higher risk for IRIS, and overall, IRIS increased the chance of death significantly. Who this helps: This research helps doctors better identify and manage risks for patients with HIV who have severely low immune function.

PubMed

The effect of pulsatile pump perfusion on hepatitis C transmission in kidney transplantation: A prospective pilot study.

2020

Clinical transplantation

Forbes RC, Concepcion BP, Clapper D, DuBray BJ, Shawar S +4 more

Plain English
This study looked at whether a method called pulsatile pump perfusion could lower the hepatitis C virus (HCV) levels in kidneys from donors who had the virus, potentially preventing its transmission during kidney transplants. Researchers found that while the pumping reduced the virus levels a bit, it wasn't enough to make a significant difference, as all transplant recipients still ended up with detectable HCV after surgery. Specifically, recipients of pumped kidneys had an average viral load of 1,352, compared to 26,170 for those without pumping, but this difference wasn't statistically significant. Who this helps: This research is important for kidney transplant patients, especially those receiving organs from HCV-positive donors.

PubMed

Exploring patient willingness to accept hepatitis C-infected kidneys for transplantation.

2020

BMC nephrology

Edwards GC, Shipe ME, Smith L, Gamble C, Shaffer D +2 more

Plain English
This study looked at how willing kidney transplant patients are to accept kidneys from donors infected with the Hepatitis C virus (HCV) compared to other high-risk donors. Out of 125 patients surveyed, 69% said they would accept an HCV-infected kidney, while fewer were open to kidneys from donors with drug use or medical issues like diabetes and hypertension. This finding is important because it shows that many patients are open to using HCV-infected kidneys, potentially increasing the number of available organs for transplant. Who this helps: This helps kidney transplant patients by expanding their options for receiving a transplant.

PubMed

Fluorescent Polysome Profiling in.

2020

Bio-protocol

Shaffer D, Rollins JA

Plain English
This research focused on a technique called fluorescent polysome profiling, which helps scientists study how genes are translated into proteins. The study found that this method allows for the measurement of how many ribosomes are actively translating RNA, which is crucial for understanding gene regulation beyond just the initial copying of DNA (transcription). By using fluorescence, researchers can get more precise information about the proteins associated with translating RNA, enhancing our understanding of how genes function in different conditions. Who this helps: This helps researchers and scientists working on gene regulation and protein production.

PubMed

A2 to B Kidney Transplantation in the Post-Kidney Allocation System Era: A 3-year Experience with Anti-A Titers, Outcomes, and Cost.

2019

Journal of the American College of Surgeons

Shaffer D, Feurer ID, Rega SA, Forbes RC

Plain English
This study looked at kidney transplants from A2 donors to B recipients over three years to see how they compared to B-to-B transplants in terms of outcomes and costs. It found that while both groups had similar survival rates and kidney function, the costs were significantly higher for A2 to B transplants, averaging $114,638 compared to $91,697 for B to B. This is important because it highlights the challenges of making organ transplants more accessible to minorities without increasing costs unsustainably. Who this helps: This helps patients, particularly those from minority backgrounds who may benefit from increased access to kidney transplants.

PubMed

A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma.

2019

Cancer

Voss MH, Bhatt RS, Vogelzang NJ, Fishman M, Alter RS +14 more

Plain English
This study looked at whether adding dalantercept to axitinib helps patients with advanced clear cell kidney cancer who had already received treatment. Among the 124 patients involved, the combination therapy did not significantly improve how long patients lived without their cancer worsening, with 6.8 months for the dalantercept group compared to 5.6 months for the placebo group. The treatment was generally well tolerated, but it did not show better outcomes, indicating that adding dalantercept might not be beneficial for these patients. Who this helps: This helps doctors understand treatment options for patients with advanced clear cell kidney cancer.

PubMed

Dietary restriction induces posttranscriptional regulation of longevity genes.

2019

Life science alliance

Rollins JA, Shaffer D, Snow SS, Kapahi P, Rogers AN

Plain English
This study looked at how eating less affects the way genes are expressed and how long organisms live. Researchers found that while certain muscle genes became more active, the way some genes related to metabolism and signaling worked was controlled after they were made, not before. They identified specific genes and processes that play a role in extending life when food is limited, showing that changes at the molecular level are important for longevity. Who this helps: This helps researchers and clinicians who study aging and dietary impacts on health.

PubMed

Implementation of telehealth is associated with improved timeliness to kidney transplant waitlist evaluation.

2018

Journal of telemedicine and telecare

Forbes RC, Broman KK, Johnson TB, Rybacki DB, Hannah Gillis AE +4 more

Plain English
This study looked at how using online tools and video calls improved the time it took for patients to get evaluated for kidney transplants at a Veterans Affairs hospital. Researchers found that when telehealth was used, patients waited just 37 days for their evaluation, compared to 260 days and 116 days in the earlier systems, with all patients being evaluated within 30 days during telehealth. This is important because it shows that telehealth can make the process of getting evaluated for a kidney transplant much faster, benefiting patients who need transplants. Who this helps: This helps patients awaiting kidney transplants.

PubMed

A Cost Comparison for Telehealth Utilization in the Kidney Transplant Waitlist Evaluation Process.

2018

Transplantation

Forbes RC, Rybacki DB, Johnson TB, Hannah-Gillis A, Shaffer D +1 more

Plain English
This study looked at the costs and time involved in evaluating patients for kidney transplants, comparing those who used telehealth to those who visited in-person. It found that patients evaluated by telehealth spent an average of $656.11, while those seen in-person spent $1,108.91, leading to total savings of over $450 per patient. Telehealth evaluations were also quicker, taking about 1.7 days compared to 2.4 days for in-person visits, which helps more people access kidney transplants faster and at a lower cost. Who this helps: This helps patients awaiting kidney transplants, particularly those with mobility issues or other health concerns.

PubMed

Increasing kidney donor profile index sequence does not adversely affect medium-term health-related quality of life after kidney transplantation.

2018

Clinical transplantation

Forbes RC, Feurer ID, LaNeve D, Concepcion BP, Gamble C +3 more

Plain English
This study looked at how the quality of kidneys from deceased donors, categorized by a Kidney Donor Profile Index (KDPI), affects the quality of life for patients after receiving a kidney transplant. Researchers followed 505 transplant recipients and found that, on average, their physical and mental health scores were similar to those of the general population about 31 months after the transplant, regardless of the KDPI of the donor kidney. This finding is important because it shows that using kidneys with a higher KDPI, which are often considered lower quality, does not lead to worse health-related quality of life for patients after transplantation. Who this helps: This benefits patients and transplant centers considering the use of high KDPI kidneys.

PubMed

Efficacy and Safety of Everolimus Plus Low-Dose Tacrolimus Versus Mycophenolate Mofetil Plus Standard-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Data.

2017

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Qazi Y, Shaffer D, Kaplan B, Kim DY, Luan FL +7 more

Plain English
This study looked at two different combinations of medications for people receiving their first kidney transplant: one group took everolimus and low-dose tacrolimus, while the other group took mycophenolate mofetil with standard-dose tacrolimus. After 12 months, the group on everolimus had slightly worse outcomes in terms of acute rejection rates (19.1% compared to 11.2%) and slightly better outcomes in terms of graft loss (1.3% compared to 3.9%). This research is important because it helps determine which treatment combination might be safer and more effective for kidney transplant patients. Who this helps: Patients receiving kidney transplants.

PubMed

Terminate lung cancer (TLC) study-A mixed-methods population approach to increase lung cancer screening awareness and low-dose computed tomography in Eastern Kentucky.

2017

Cancer epidemiology

Cardarelli R, Reese D, Roper KL, Cardarelli K, Feltner FJ +5 more

Plain English
This study focused on increasing awareness and participation in low-dose CT lung cancer screening in Eastern Kentucky. The researchers used community feedback to create a targeted outreach campaign and then compared screening rates in these areas to a control region. They found that this campaign effectively raised awareness and increased screening rates, although specific numbers weren't provided. Who this helps: This benefits patients at risk for lung cancer by encouraging earlier detection and treatment.

PubMed

A2 to B Blood Type Incompatible Deceased Donor Kidney Transplantation in a Recipient Infected with the Human Immunodeficiency Virus: A Case Report.

2017

Transplantation proceedings

Forbes RC, DeMers A, Concepcion BP, Moore DR, Schaefer HM +1 more

Plain English
This study looked at a case of kidney transplantation from an A2 blood type donor to a B blood type recipient who is also infected with HIV. The 39-year-old man, who had kidney failure, successfully received the transplant with no signs of rejection, and his kidney function improved, with his creatinine levels reaching 2.0 mg/dL post-surgery. This research is important because it shows that A2 kidneys can be safely transplanted to HIV-positive patients with B blood types, potentially increasing the number of available kidneys for these patients. Who this helps: This benefits HIV-positive patients who need kidney transplants.

PubMed

Association of Clinical Events With Everolimus Exposure in Kidney Transplant Patients Receiving Low Doses of Tacrolimus.

2017

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Shihab F, Qazi Y, Mulgaonkar S, McCague K, Patel D +2 more

Plain English
This study looked at how different levels of the drug everolimus (EVR) affect kidney transplant patients who are also taking low doses of a medicine called tacrolimus. Researchers found that patients with EVR levels below 3 ng/mL experienced higher rates of kidney rejection (64.7%) and graft loss (10.5%), while patients with higher EVR levels had fewer rejection events. This is important because it helps determine the right dosage of EVR to improve kidney transplant outcomes while keeping patients safe. Who this helps: This benefits kidney transplant patients and their doctors by guiding medication management for better transplant success.

PubMed

Comparison of Two Types of Meditation on Patients' Psychosocial Responses During Radiation Therapy for Head and Neck Cancer.

2017

Journal of alternative and complementary medicine (New York, N.Y.)

Boxleitner G, Jolie S, Shaffer D, Pasacreta N, Bai M +1 more

Plain English
This study examined how two types of meditation—one with a coach and another using a CD—affect the emotional well-being of patients undergoing radiation therapy for head and neck cancer. Researchers found that both meditation methods helped reduce anxiety, depression, and emotional distress over 12 weeks; however, there were no significant differences between the two groups. This matters because it shows that both approaches are effective, but self-meditation with a CD is a more affordable option for patients. Who this helps: Patients undergoing radiation therapy for head and neck cancer.

PubMed

Parent-Adolescent Acculturation Gap and Suicidal Ideation among Adolescents from an Emergency Department.

2017

Archives of suicide research : official journal of the International Academy for Suicide Research

Ortin A, Miranda R, Polanco-Roman L, Shaffer D

Plain English
This study looked at how differences in cultural adaptation between parents and their teenagers affect the likelihood of teens thinking about suicide. Researchers found that when there is a large gap between how much parents and teens adapt to a new culture, teens are more likely to react emotionally and have suicidal thoughts. In contrast, smaller gaps were linked to increased feelings of hopelessness and suicidal thoughts. Understanding these cultural differences is important for identifying and supporting at-risk teens in emergency situations. Who this helps: This helps adolescents facing cultural challenges and their parents, as well as mental health professionals.

PubMed

A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma.

2017

Annals of oncology : official journal of the European Society for Medical Oncology

Voss MH, Hussain A, Vogelzang N, Lee JL, Keam B +15 more

Plain English
This study looked at a new treatment called CRLX101 combined with bevacizumab for patients with advanced kidney cancer that had not responded to previous treatments. It involved 111 participants and found that the average time before the cancer worsened was about 3.7 months with the new treatment, compared to 3.9 months with standard treatments. However, the combination did not show any significant benefits over the current standard of care, leading researchers to conclude that they will not continue to develop this treatment for this type of cancer. Who this helps: This helps doctors and patients by providing clarity on treatment options for advanced kidney cancer.

PubMed

Exploring the impact of route of administration on medication acceptance in hospitalized patients: Implications for venous thromboembolism prevention.

2017

Thrombosis research

Popoola VO, Tavakoli F, Lau BD, Lankiewicz M, Ross P +7 more

Plain English
This study looked at how often hospitalized patients didn’t receive their prescribed medications for preventing dangerous blood clots (venous thromboembolism or VTE) compared to other types of medications. Researchers found that patients did not receive subcutaneous (injection) VTE prophylaxis nearly four times more often than they missed doses of oral medications for infections or heart issues. The results indicate that making an oral version of VTE prophylaxis available could help ensure more patients receive the protection they need against blood clots. Who this helps: This benefits patients at risk of developing blood clots during hospital stays.

PubMed

A comparison of patency and interventions in thigh versus Hemodialysis Reliable Outflow grafts for chronic hemodialysis vascular access.

2016

Journal of vascular surgery

Brownie ER, Kensinger CD, Feurer ID, Moore DE, Shaffer D

Plain English
This study looked at two types of grafts used for patients on long-term dialysis: thigh grafts and HeRO grafts. Researchers found that thigh grafts lasted much longer than HeRO grafts; for example, after one year, 46% of thigh grafts were still functional compared to just 15% of HeRO grafts. This matters because using thigh grafts can mean fewer complications and less frequent procedures to keep blood flow going for dialysis patients. Who this helps: Patients with chronic kidney disease requiring dialysis.

PubMed

Frequent Co-Authors

Rachel C Forbes Beatrice P Concepcion Irene D Feurer Scott A Rega Rachel Forbes Saed Shawar Laura A Binari Peter P Reese Douglas E Schaubel Raymond T Chung

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.